Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Efficacy and Safety of DLBS3233 in Subjects With New Onset of Type 2 Diabetes Mellitus

This study has been completed.
Information provided by (Responsible Party):
Dexa Medica Group Identifier:
First received: July 18, 2012
Last updated: October 7, 2014
Last verified: October 2014
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: September 2014
  Primary Completion Date: August 2014 (Final data collection date for primary outcome measure)